Table 3.
Test | Manufacturer | Technology | Analytical time, min | Sample type | Age of intended patient population, years | Sensitivity range,a % (95% CI) | Specificity range,b % (95% CI) | Studies, n | References |
---|---|---|---|---|---|---|---|---|---|
Waived | |||||||||
BD Veritor System RSV | Becton, Dickinson and Company | Antigen | 10 | Nasopharyngeal swab | <6 years | 67.5 (56.1–77.6) to 97.6 (NRc) | 96.8 (91.1–99.3) to 100 (97.0–100) | 7 | (25–31) |
Alere Binax NOW RSV | Abbott | Antigen | 15 | Nasopharyngeal swab and nasopharyngeal aspirate/wash | <5 years | 41.2 (NR) to 90 (NR) | 93.2 (92.8–93.6) to 100.0 (97–100) | 13 | (32–44) |
cobas Liat Influenza A/B & RSV Assay | Roche Diagnostics | Molecular | 20 | Nasopharyngeal swab | Not specified | 94.2 (87.9–97.9) to 100.0 (96.07–100.0) | 94.29 (86.01–98.42) to 100 (97.7–100) | 7 | (15, 45–50) |
ID NOW RSVd | Abbott | Molecular | 13 | Nasopharyngeal swab | <18 years and ≥60 years | 93 (89–96) to 100 (93–100) | 96 (93–98) to 98.0 (95.8–99.1) | 4 | (15, 51–53) |
QuickVue RSV | Quidel | Antigen | 15 | Nasopharyngeal swab and nasopharyngeal aspirate and/or nasal wash | ≤18 years | 25.7 (NR) to 90.1 (86.8–93.4) | 98.5 (NR) to 99.5 (92–99) | 4 | (30, 54–56) |
Sofia RSV FIAe | Quidel | Antigen | 15 | Nasopharyngeal swab and nasopharyngeal aspirate/wash | <19 years | 74.8 (68.0–80.9) to 100 (82–100) | 86.8 (85.7–87.4) to 100 (95.2–100) | 8 | (29, 30, 33, 41, 43, 57–59) |
Xpert Xpress Flu/RSV | Cepheid | Molecular | 30 | Nasopharyngeal swab and/or nasal swab | Not specified | 66.7 (24.1–94.0) to 98.1 (88.8–99.9) | 98.1 (96.6–99.0) to 100 (99.7–100) | 5 | (45, 60–63) |
Moderate complexity | |||||||||
3M Rapid Detection RSV Test | 3M Health Care | Antigen | 15 | Nasopharyngeal swab and nasopharyngeal aspirate and/or nasal wash | ≤21 years | 60.0 (38.5–81.5) to 87.3 (83.8–90.1) | 95.6 (93.8–96.9) to 99.6 (98.7–100) | 2 | (64, 65) |
Aries Flu A/B & RSV Assay | Luminex Corporation | Molecular | 120 | Nasopharyngeal swab | Not specified | 88.6 (58.3–97.6) to 97.1 (94.4–98.7) | 98.4 (97.7–98.9) to 100.0 (98.8–100) | 4 | (44, 45, 47, 66) |
BioFire FilmArray Respiratory 2.1 Panel | bioMérieux | Molecular | 45 | Nasopharyngeal swab | Not specified | 62.5 (24.5–91.5) to 99.4 (96.9–99.9) | 98.3 (97.5–98.9) to 100 (97.2–100) | 4 | (45, 67–69) |
Directigen EZ RSV | Becton, Dickinson and Company | Antigen | 15 | Not specified | <20 years | 59 (NR) to 90 (NR) | 89.5 (NR) to 99.5 (97.0–100) | 6 | (30, 32, 42, 70–72) |
ePlex Respiratory Pathogen Panel | GenMark Diagnostics | Molecular | 120 | Nasopharyngeal swab | Not specified | 89.6 (80.0–94.8) to 100 (92.6–100) | 98.9 (94.2–99.8) to 100 (99.8–100) | 2 | (73, 74) |
High complexity | |||||||||
Panther Fusion Flu A/B/RSV Assay | Hologic, Inc. | Molecular | Not reported | Nasopharyngeal swab | Not specified | 88.4 (81.1–93.1) to 100 (NR) | 98.7 (97.0–99.6) to 100 (99.7–100) | 6 | (45, 47, 74–77) |
Simplexa Flu A/B & RSV | Diasorin Molecular | Molecular | 60 | Nasopharyngeal swab | Not specified | 73.3 (44.8–91.0) to 87.0 (74.5–94.2) | 99.4 (96.3–99.9) to 100 (98.9–100) | 3 | (45, 47, 78) |
Sensitivity and specificity ranges are not reported for RSV tests with <3 supporting subrecords.
Specificity ranges are not reported for RSV tests with <3 supporting subrecords.
Not reported.
The ID NOW RSV was formerly known as the Alere i RSV.
Fluorescence immunoassay.